Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
Clinical trial NCT02655601 · COMPLETED
Trial details
- NCT number
- NCT02655601
- Sponsor
- BioMimetix JV, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2023-08-17
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.